Your browser doesn't support javascript.
loading
Reliability of the Apathy Evaluation Scale in Myotonic Dystrophy Type 1.
Gallais, Benjamin; Gagnon, Cynthia; Côté, Isabelle; Forgues, Geneviève; Laberge, Luc.
Afiliação
  • Gallais B; Groupe de recherche interdisciplinaire sur les maladies neuromusculaires (GRIMN), CSSS de Jonquière, G7X 7X2 Saguenay, QC, Canada.
  • Gagnon C; Centre de recherche Charles-Le-Moyne, Faculty of Medecine and Health Sciences, Université de Sherbrooke, QC, Canada.
  • Côté I; Groupe de recherche interdisciplinaire sur les maladies neuromusculaires (GRIMN), CSSS de Jonquière, G7X 7X2 Saguenay, QC, Canada.
  • Forgues G; Centre de recherche Charles-Le-Moyne, Faculty of Medecine and Health Sciences, Université de Sherbrooke, QC, Canada.
  • Laberge L; Groupe de recherche interdisciplinaire sur les maladies neuromusculaires (GRIMN), CSSS de Jonquière, G7X 7X2 Saguenay, QC, Canada.
J Neuromuscul Dis ; 5(1): 39-46, 2018.
Article em En | MEDLINE | ID: mdl-29278897
ABSTRACT

BACKGROUND:

Apathy is a common debilitating symptom of myotonic dystrophy type 1 (DM1). The Apathy Evaluation Scale (AES) has been identified as a promising measurement instrument to be used in DM1 but its metrological properties must be further documented.

OBJECTIVE:

To determine the internal consistency of the Self (AES-S), Informant (AES-I), and Clinician (AES-C) versions of the AES and to assess the test-retest reliability, standard error of measurement, and minimal detectable change of the AES-S and AES-I in a sample of DM1 patients and their related informants.

RESULTS:

All scales showed good internal consistency (Cronbach's alpha 0.83-0.87) and the AES-S and AES-I showed good test-retest reliability (ICC = 0.79-0.91). Additionally, clinicians and informants had a tendency to overestimate DM1 patients' level of apathy compared to patients' self-ratings, suggesting potentially impaired self-awareness in DM1 patients.

CONCLUSIONS:

The present results advocate the use of the AES-I as a reliable instrument to estimate apathy in DM1 patients for either clinical or research purposes, and support the relevance to pursue the assessment of metrological properties of the AES as a tool of great value for the development of outcomes for clinical trial readiness in DM1.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pessoal de Saúde / Autorrelato / Apatia / Distrofia Miotônica Tipo de estudo: Clinical_trials / Prognostic_studies / Qualitative_research Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neuromuscul Dis Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pessoal de Saúde / Autorrelato / Apatia / Distrofia Miotônica Tipo de estudo: Clinical_trials / Prognostic_studies / Qualitative_research Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neuromuscul Dis Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Canadá